Stacey Farrell, CNP

Stacey Farrell practices at Magnolia Medical Clinic P.A. in Fort Walton Beach, Florida.

Stacey Farrell's NPI, 1154763514, was assigned on July 25, 2013. Stacey Farrell holds Mississippi license R855653.

Stacey Farrell's primary practice is Magnolia Medical Clinic P.A., at 319 Green Acres Rd, Fort Walton Beach, FL 32547 in Okaloosa County. The practice phone is (850) 243-7681.

Stacey Farrell's primary practice is Magnolia Medical Clinic P.A. in Fort Walton Beach, Florida. The medical group on file is Clearway Pain Solutions. Dmand AI also links Stacey Farrell to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stacey Farrell practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Stacey Farrell's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Stacey Farrell is licensed in Mississippi.

Dmand AI lists acute skin infection, asthma, bronchitis, chronic nasal allergies, lower back pain, shingles, upper respiratory infection (URI) and UTI among the conditions Stacey Farrell treats.

CMS data shows 35 Medicare services from Stacey Farrell across 2 procedure codes in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $2,194 for them. Every service was in an office.

CMS counts 31 Medicare patients who saw Stacey Farrell in 2024. The largest group is 65 to 74, with 19 patients. 74% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Stacey Farrell's median patient age at 69, with 43% women.

In 2024, Stacey Farrell wrote 77 Medicare Part D claims for 18 patients. 94% of them were for generic drugs.

Stacey Farrell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Stacey Farrell from 6 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $59.